Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / CL A SHS
-
Total 13F shares
-
10,966,181
-
Share change
-
+281,321
-
Total reported value
-
$110,369,337
-
Price per share
-
$10.07
-
Number of holders
-
49
-
Value change
-
+$2,871,495
-
Number of buys
-
11
-
Number of sells
-
15
Institutional Holders of MEDICUS SCIENCES ACQUISITION - CL A SHS (MSAC) as of Q4 2022
As of 31 Dec 2022,
MEDICUS SCIENCES ACQUISITION - CL A SHS (MSAC) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,966,181 shares.
The largest 10 holders included
Sio Capital Management, LLC, GLAZER CAPITAL, LLC, Saba Capital Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., First Trust Capital Management L.P., Avidity Partners Management LP, D. E. Shaw & Co., Inc., Westchester Capital Management, LLC, Cubist Systematic Strategies, LLC, and MIZUHO SECURITIES USA LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.